What class is the FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB trademark registered in?

The FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB trademark is registered in Class 036 (Insurance, financial & real estate services), Class 042 (Scientific, technology & SaaS services).

What is the serial number for FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB?

The USPTO serial number for FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB is 97276900.

What is the registration number for FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB?

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB is registered under USPTO registration number 7011438.

FUS

USPTO Trademark Record

REGISTERED

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB

SN 97276900·Reg 7011438·Filed Feb 21, 2022

Owner Fosun Pharma USA Inc.

Financial, monetary and banking services; insurance services; real estate services.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB (Serial No. 97276900), Registration No. 7011438, is a registered US trademark filed on Feb 21, 2022 by Fosun Pharma USA Inc.. This trademark covers Class 036 (Insurance, financial & real estate services), Class 042 (Scientific, technology & SaaS services).

early section 8: March 28, 2029

Mark Intelligence

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB (Reg. #7011438) is a registered US trademark that has been protecting its owner, Fosun Pharma USA Inc., since 2022. The mark covers Class 036 (Insurance, financial & real estate services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Financial, monetary and banking services; insurance services; real estate services.; Scientific and technological servic.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 21, 2022

SERIAL

97276900

REG#

7011438

REGISTERED

Mar 28, 2023

Owner

Applicant

Fosun Pharma USA Inc.

Entity

Corporation

State

Address

91 Hartwell Avenue, Lexington, MA, 02421

Country

Attorney

NamePerry Gattegno

Law firm

PERRY GATTEGNO LITWIN KACH LLP

Address

200 N LASALLE, SUITE 1550, CHICAGO, IL 60606, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 21, 2022

Serial Number97276900

Registration No.7011438

Registration DateMar 28, 2023

Status DateMar 28, 2023

Published for OppositionJan 10, 2023

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 036Insurance, financial & real estate services

US codes: 100, 101, 102

First use anywhere: Aug 31, 2020

First use in commerce: Aug 31, 2020

Financial, monetary and banking services; insurance services; real estate services.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Aug 31, 2020

First use in commerce: Aug 31, 2020

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

10 events

REGISTERED-PRINCIPAL REGISTER

Mar 28, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 28, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 10, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 10, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 21, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 06, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 05, 2022

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 25, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Feb 24, 2022

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 24, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Fosun Pharma USA Inc.

Other Marks in Class 036 — Insurance, financial & real estate services

Other Marks by Perry Gattegno

Resources

Company